Brian A. Kidd

Brian A. Kidd

Auto-generated profile, based on publicly available information

Brian A. Kidd

Bristol-Myers Squibb, Princeton, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2016 in Scientific Reports
Verified
Journal Article
Open access
RMRiccardo Miotto
Riccardo Miotto
LLLi Li
Li Li
BKBrian A. Kidd
Brian A. Kidd
JDJoel T. Dudley
Joel T. Dudley
Secondary use of electronic health records (EHRs) promises to advance clinical research and better inform clinical decision making. Challenges in summarizing and representing patient data prevent widespread practice of predictive modeling using EHRs. Here we present a novel unsupervised deep feature learning method to derive a general-purpose patient representation from EHR data that facilitates clinical predictive modeling. In particular, a three-layer stack of denoising autoencoders was used to capture hierarchical regularities and dependencies in the aggregated EHRs of about 700,000 patients from the Mount Sinai data warehouse. The result is a representation we name “deep patient”. We evaluated this representation as broadly predictive of health states by assessing the probability of patients to develop various diseases. We performed evaluation using 76,214 test patients comprising 78 diseases from diverse clinical domains and temporal windows. Our results significantly outperformed those achieved using representations based on raw EHR data and alternative feature learning strategies. Prediction performance for severe diabetes, schizophrenia, and various cancers were among the top performing. These findings indicate that deep learning applied to EHRs can derive patient representations that offer improved clinical predictions, and could provide a machine learning framework for augmenting clinical decision systems.

4 November 2005 in Science
Verified
Journal Article
Closed access
PDF file
MPMichael Platten
Michael Platten
PHPeggy P. Ho
Peggy P. Ho
SYSawsan Youssef
Sawsan Youssef
PFPaulo Fontoura
Paulo Fontoura
HGHideki Garren
Hideki Garren
LSLawrence Steinman
Lawrence Steinman
Local catabolism of the amino acid tryptophan (Trp) by indoleamine 2,3-dioxygenase (IDO) is considered an important mechanism of regulating T cell immunity. We show that IDO transcription was increased when myelin-specific T cells were stimulated with tolerogenic altered self-peptides. Catabolites of Trp suppressed proliferation of myelin-specific T cells and inhibited production of proinflammatory T helper–1 (T H 1) cytokines. N -(3,4,-Dimethoxycinnamoyl) anthranilic acid (3,4-DAA), an orally active synthetic derivative of the Trp metabolite anthranilic acid, reversed paralysis in mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis (MS). Trp catabolites and their derivatives offer a new strategy for treating T H 1-mediated autoimmune diseases such as MS.

15 April 2016 in WIREs Mechanisms of Disease
Verified
Journal Article
Closed access
PDF file
RHRachel A. Hodos
Rachel A. Hodos
BKBrian A. Kidd
Brian A. Kidd
KSKhader Shameer
Khader Shameer
BRBen P. Readhead
Ben P. Readhead
JDJoel T. Dudley
Joel T. Dudley

1 April 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DFDavid Furman
David Furman
VJVladimir Jojic
Vladimir Jojic
SSShalini Sharma
Shalini Sharma
SSShai S. Shen-Orr
Shai S. Shen-Orr
CACesar J. L. Angel
Cesar J. L. Angel
MDMark M. Davis
Mark M. Davis
Cytomegalovirus (CMV) is a β-herpesvirus present in a latent form in most people worldwide. In immunosuppressed individuals, CMV can reactivate and cause serious clinical complications, but the effect of the latent state on healthy people remains elusive. We undertook a systems approach to understand the differences between seropositive and negative subjects and measured hundreds of immune system components from blood samples including cytokines and chemokines, immune cell phenotyping, gene expression, ex vivo cell responses to cytokine stimuli, and the antibody response to seasonal influenza vaccination. As expected, we found decreased responses to vaccination and an overall down-regulation of immune components in aged individuals regardless of CMV status. In contrast, CMV-seropositive young adults exhibited enhanced antibody responses to influenza vaccination, increased CD8+ T cell sensitivity, and elevated levels of circulating interferon-γ compared to seronegative individuals. Experiments with young mice infected with murine CMV also showed significant protection from an influenza virus challenge compared with uninfected animals, although this effect declined with time. These data show that CMV and its murine equivalent can have a beneficial effect on the immune response of young, healthy individuals, which may explain the ubiquity of CMV infection in humans and many other species.

9 June 2013 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
ENEvan W Newell
Evan W Newell
NSNatalia Sigal
Natalia Sigal
NNNitya Nair
Nitya Nair
BKBrian A Kidd
Brian A Kidd
HGHarry B. Greenberg
Harry B. Greenberg
MDMark M Davis
Mark M Davis

1 May 2010 in Cell
Verified
Journal Article
Closed access
ITIsolde Le Trong
Isolde Le Trong
PAPavel Aprikian
Pavel Aprikian
BKBrian A. Kidd
Brian A. Kidd
MFManu Forero-Shelton
Manu Forero-Shelton
VTVeronika Tchesnokova
Veronika Tchesnokova
WTWendy Evelyn Thomas
Wendy Evelyn Thomas